What are the characteristics of impetigo rashes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Characteristics of Impetigo Rashes

Impetigo is characterized by two main types: nonbullous impetigo (70% of cases) with honey-colored crusted erosions, and bullous impetigo (30% of cases) with fragile, thin-roofed vesicopustules caused by toxin-producing strains of S. aureus. 1, 2

Nonbullous Impetigo (Impetigo Contagiosa)

  • Caused by Staphylococcus aureus, Streptococcus pyogenes, or both in combination 1
  • Begins as erythematous papules that rapidly evolve into vesicles and pustules 1
  • Develops honey-colored crusts after pustules rupture, typically affecting the face and extremities 2
  • May occur as primary infection through minor breaks in skin or secondary infection of existing dermatoses 3
  • Most commonly affects children 2-5 years of age 2

Bullous Impetigo

  • Caused exclusively by toxin-producing strains of S. aureus 1
  • Characterized by fragile, thin-roofed vesicopustules that form when toxins cleave the dermal-epidermal junction 1
  • Results in large, flaccid bullae that are more likely to affect intertriginous areas 2
  • Represents the milder end of a spectrum that includes staphylococcal scalded skin syndrome 4
  • Bacteria can be cultured from the blister contents 4

Ecthyma

  • Deeper infection than impetigo, caused by S. aureus and/or streptococci 1
  • Begins as vesicles that rupture, resulting in circular, erythematous ulcers with adherent crusts 1
  • Penetrates through the epidermis into the dermis, unlike superficial impetigo 1

Clinical Course and Complications

  • Both types usually resolve within 2-3 weeks without scarring 2
  • Complications are rare, with the most serious being poststreptococcal glomerulonephritis 2
  • Highly contagious, especially among children 3

Diagnostic Features

  • Diagnosis is typically made clinically based on characteristic appearance 5
  • Cultures of vesicle fluid, pus, erosions, or ulcers may be obtained to establish the cause, especially in cases of:
    • Treatment failure
    • Suspected MRSA
    • Recurrent infections 1

Distribution Patterns

  • Face and extremities are common sites for nonbullous impetigo 2
  • Intertriginous areas are more commonly affected in bullous impetigo 2
  • Can occur in specific locations such as scalp or nose with characteristic presentations 6, 7

Key Distinguishing Features

  • Nonbullous: honey-colored crusts, primarily on exposed areas 2
  • Bullous: fluid-filled vesicles and flaccid blisters 4
  • Ecthyma: deeper ulcers with adherent crusts 1

Common Pitfalls in Diagnosis

  • May be confused with other vesiculobullous conditions or dermatitis 2
  • Secondary impetigo may mask underlying skin conditions 3
  • Increasing prevalence of antibiotic-resistant bacteria, particularly community-acquired MRSA, can complicate clinical presentation and treatment response 3

References

Guideline

Impetigo Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Impetigo: diagnosis and treatment.

American family physician, 2014

Research

Diagnosis and treatment of impetigo.

American family physician, 2007

Guideline

Treatment of Scalp Impetigo

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Impetigo in the Nose

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.